POTS Cases Surge 130% Post-Pandemic, Driving Shift Toward Autoimmune Treatments
Postural orthostatic tachycardia syndrome (POTS) has seen a 130% increase in incidence since 2020, with rates jumping from 430 to 990 cases per month. While previously underdiagnosed, especially in young women, the condition is now linked to autoimmune mechanisms. Clinicians are shifting from symptom management to immune-modifying therapies, as emerging evidence suggests POTS and Long COVID may share identical immunological profiles.